D. Moreno‐Ramírez

5.8k total citations
143 papers, 1.8k citations indexed

About

D. Moreno‐Ramírez is a scholar working on Oncology, Dermatology and Epidemiology. According to data from OpenAlex, D. Moreno‐Ramírez has authored 143 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Oncology, 61 papers in Dermatology and 50 papers in Epidemiology. Recurrent topics in D. Moreno‐Ramírez's work include Cutaneous Melanoma Detection and Management (70 papers), Nonmelanoma Skin Cancer Studies (43 papers) and Cutaneous lymphoproliferative disorders research (25 papers). D. Moreno‐Ramírez is often cited by papers focused on Cutaneous Melanoma Detection and Management (70 papers), Nonmelanoma Skin Cancer Studies (43 papers) and Cutaneous lymphoproliferative disorders research (25 papers). D. Moreno‐Ramírez collaborates with scholars based in Spain, Italy and Belgium. D. Moreno‐Ramírez's co-authors include Lara Ferrándiz, J.J. Ríos-Martín, María Adoración Nieto García, Francisco M. Camacho, Rafael Galdeano, A. Ruíz-de-Casas, P. de la Cueva, Josep Malvehy, Francisco Camacho and Rafael Carrasco and has published in prestigious journals such as Frontiers in Immunology, Journal of the American Academy of Dermatology and British Journal of Dermatology.

In The Last Decade

D. Moreno‐Ramírez

132 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Moreno‐Ramírez Spain 23 999 819 630 259 202 143 1.8k
Lara Ferrándiz Spain 18 763 0.8× 523 0.6× 448 0.7× 160 0.6× 102 0.5× 94 1.2k
Marc van Beurden Netherlands 29 811 0.8× 346 0.4× 1.1k 1.8× 260 1.0× 225 1.1× 95 3.6k
Jennifer Stein United States 20 714 0.7× 415 0.5× 353 0.6× 99 0.4× 118 0.6× 97 1.5k
Jeremy S. Bordeaux United States 26 1.1k 1.1× 906 1.1× 996 1.6× 164 0.6× 152 0.8× 154 2.4k
Santosh G Honavar India 41 1.1k 1.1× 554 0.7× 705 1.1× 151 0.6× 663 3.3× 254 5.7k
Johan Bulten Netherlands 40 1.1k 1.1× 359 0.4× 2.7k 4.3× 247 1.0× 213 1.1× 206 5.4k
Jason K. Rivers Canada 28 1.4k 1.4× 1.5k 1.8× 650 1.0× 189 0.7× 174 0.9× 127 2.9k
David Slater United Kingdom 25 539 0.5× 539 0.7× 665 1.1× 164 0.6× 327 1.6× 130 2.2k
Shasa Hu United States 17 714 0.7× 545 0.7× 417 0.7× 100 0.4× 78 0.4× 43 1.4k
John Balser United States 24 501 0.5× 318 0.4× 213 0.3× 347 1.3× 641 3.2× 41 2.2k

Countries citing papers authored by D. Moreno‐Ramírez

Since Specialization
Citations

This map shows the geographic impact of D. Moreno‐Ramírez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Moreno‐Ramírez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Moreno‐Ramírez more than expected).

Fields of papers citing papers by D. Moreno‐Ramírez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Moreno‐Ramírez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Moreno‐Ramírez. The network helps show where D. Moreno‐Ramírez may publish in the future.

Co-authorship network of co-authors of D. Moreno‐Ramírez

This figure shows the co-authorship network connecting the top 25 collaborators of D. Moreno‐Ramírez. A scholar is included among the top collaborators of D. Moreno‐Ramírez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Moreno‐Ramírez. D. Moreno‐Ramírez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rodríguez‐Martínez, Alba, N. Blázquez-Sánchez, Francisco Rivas‐Ruiz, et al.. (2025). Are workers protected? Analyzing sun protection policies in Andalusian municipalities. Public Health. 247. 105884–105884.
2.
Bossi, Paolo, Paolo A. Ascierto, Nicole Basset‐Séguin, et al.. (2023). Long-term strategies for management of advanced basal cell carcinoma with hedgehog inhibitors. Critical Reviews in Oncology/Hematology. 189. 104066–104066. 21 indexed citations
3.
Coto‐Segura, Pablo, Antonio Martorell, D. Moreno‐Ramírez, et al.. (2023). A quantitative systems pharmacology model for certolizumab pegol treatment in moderate-to-severe psoriasis. Frontiers in Immunology. 14. 1212981–1212981. 4 indexed citations
4.
Ferrándiz, Lara, et al.. (2023). Difficult to Diagnose Cutaneous Melanoma in a Patient with BAP1 Tumor Predisposition Syndrome. International Journal of Surgical Pathology. 31(7). 1398–1402. 2 indexed citations
5.
6.
Ramos, Jaime, et al.. (2022). Effectiveness and safety of topical 15% resorcinol in the management of mild‐to‐moderate hidradenitis suppurativa: A cohort study. The Journal of Dermatology. 49(4). 459–462. 5 indexed citations
7.
8.
Moreno‐Ramírez, D., et al.. (2021). Surgery for Cutaneous Squamous Cell Carcinoma and its Limits in Advanced Disease. Dermatology Practical & Conceptual. 11(S2). e2021167S–e2021167S. 8 indexed citations
9.
Boada, Aram, A. Tejera‐Vaquerizo, Simone Ribero, et al.. (2020). Age as a prognostic factor in thick and ultrathick melanomas without lymph node metastasis. Journal of the European Academy of Dermatology and Venereology. 34(9). e513–e517. 5 indexed citations
10.
Botella‐Estrada, Rafael, Aram Boada, María Teresa Fernández‐Figueras, et al.. (2020). Guía de práctica clínica de melanoma de la Academia Española de Dermatología y Venereología. Actas Dermo-Sifiliográficas. 112(2). 142–152. 6 indexed citations
11.
Podlipnik, Sebastián, D. Moreno‐Ramírez, Cristina Carrera, et al.. (2018). Cost‐effectiveness analysis of imaging strategy for an intensive follow‐up of patients with American Joint Committee on Cancer stage IIB , IIC and III malignant melanoma. British Journal of Dermatology. 180(5). 1190–1197. 19 indexed citations
12.
Moreno‐Ramírez, D., Aram Boada, Lara Ferrándiz, et al.. (2018). Disección ganglionar en el paciente con melanoma y metástasis en el ganglio centinela: propuesta de decisión basada en la evidencia actual. Actas Dermo-Sifiliográficas. 109(5). 390–398. 4 indexed citations
13.
Moreno‐Ramírez, D., Ricardo Ruíz‐Villaverde, M. de Troya‐Martín, et al.. (2016). Proceso de atención a las personas con lesiones quísticas y tumorales benignas. Documento de consenso de la sección territorial andaluza de la Academia Española de Dermatología Médico-Quirúrgica y Venereología. Actas Dermo-Sifiliográficas. 107(5). 391–399. 6 indexed citations
14.
Cueva, P. de la, et al.. (2015). Cost-Utility Analysis of Ingenol Mebutate Versus Imiquimod 5% for Actinic Keratosis Treatment In Spain. Value in Health. 18(7). A423–A423. 2 indexed citations
15.
Domínguez‐Gil, A., et al.. (2011). PSS20 Annual Cost of Biological Therapies for the Treatment of Moderate to Severe Plaque Psoriasis in Spain. Value in Health. 14(7). A505–A505. 3 indexed citations
16.
Moreno‐Ramírez, D.. (2011). Uso racional (eficiente) de biológicos y terapia intermitente en psoriasis. Actas Dermo-Sifiliográficas. 102(4). 241–243. 4 indexed citations
17.
Moreno‐Ramírez, D., et al.. (2007). China, Precios de Commodities y Desempeño de América Latina: Algunos Hechos Estilizados. Dialnet (Universidad de la Rioja). 1.
18.
Moreno‐Ramírez, D., Lara Ferrándiz, María Adoración Nieto García, et al.. (2007). Store-and-Forward Teledermatology in Skin Cancer Triage. Archives of Dermatology. 143(4). 479–84. 139 indexed citations
19.
Tapia, Mikel, et al.. (2005). Mercados de Agentes Computacionales. 63–65. 1 indexed citations
20.
Moreno‐Ramírez, D., et al.. (2003). Diagnóstico y tratamiento de los linfomas cutáneos primarios de células T. Revista Medicina Cutánea Ibero-Latino-Americana. 31(2). 75–100. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lara Ferrándiz Breakdown of academic impact, for papers by Marc van Beurden Breakdown of academic impact, for papers by Jennifer Stein Breakdown of academic impact, for papers by Jeremy S. Bordeaux Breakdown of academic impact, for papers by Santosh G Honavar Breakdown of academic impact, for papers by Johan Bulten Breakdown of academic impact, for papers by Jason K. Rivers Breakdown of academic impact, for papers by David Slater Breakdown of academic impact, for papers by Shasa Hu Breakdown of academic impact, for papers by John Balser
Rankless by CCL
2026